CACNA1D mutations have previously been associated with primary aldosteronism, seizures, and neurologic abnormalities (PASNA; OMIM #615474), thus suggesting a disease spectrum that may include CHI with reduced penetrance. The gene discussed is CACNA1D; the disease is congenital isolated hyperinsulinism.